Meridian Bioscience reported $194.98M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Accelerate Diagnostics AXDX:US 71.52M 12.18M
Atrion ATRI:US 133.77M 7.94M
Becton, Dickinson and BDX:US $ 8838M 700M
Bio Rad Laboratories BIO:US $ 2466.29M 177.19M
Cerulean Pharma CERU:US $ 48.24M 34.18M
Cerus CERS:US $ 178.05M 7.54M
Genmark Diagnostics GNMK:US $ 172.96M 2.95M
Luminex LMNX:US $ 481.78M 27.25M
Myriad Genetics MYGN:US $ 498.9M 40M
Neogen NEOG:US $ 609.95M 0.83M
Orasure Technologies OSUR:US $ 289.23M 4.18M
Oxford Immunotec Global OXFD:US $ 188.37M 1.42M
Quidel QDEL:US $ 1149.06M 231.38M
Rockwell Medical RMTI:US $ 46.08M 6.32M
Sientra SIEN:US 146.78M 4.76M
Staar Surgical STAA:US $ 263.94M 15.83M
Thermo Fisher Scientific TMO:US $ 24724M 5464M
Trinity Biotech TRIB:US $ 78.25M 3.22M
Utah Medical Products UTMD:US $ 75.85M 9.23M